Will the adcomm vote against IPCI's Rexista help EGLT? Does not look good for FDA approval anymore since the committee voted overwhelmingly NO. I picked up some when i looked bad for IPCI and hoping I will get some money back via EGLT. I need to rode it to $4/share, I hope we can do that in a year. Just wondering what people think because it doesn't look good for anymore players in this field of opioids to get approved anytime soon.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.